These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38994031)

  • 21. FOXA1/UBE2T Inhibits CD8
    Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity.
    Büll C; Boltje TJ; Balneger N; Weischer SM; Wassink M; van Gemst JJ; Bloemendal VR; Boon L; van der Vlag J; Heise T; den Brok MH; Adema GJ
    Cancer Res; 2018 Jul; 78(13):3574-3588. PubMed ID: 29703719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbomer-based adjuvant elicits CD8 T-cell immunity by inducing a distinct metabolic state in cross-presenting dendritic cells.
    Lee W; Kingstad-Bakke B; Paulson B; Larsen A; Overmyer K; Marinaik CB; Dulli K; Toy R; Vogel G; Mueller KP; Tweed K; Walsh AJ; Russell J; Saha K; Reyes L; Skala MC; Sauer JD; Shayakhmetov DM; Coon J; Roy K; Suresh M
    PLoS Pathog; 2021 Jan; 17(1):e1009168. PubMed ID: 33444400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment.
    Qiao G; Chen M; Mohammadpour H; MacDonald CR; Bucsek MJ; Hylander BL; Barbi JJ; Repasky EA
    Cancer Immunol Res; 2021 Jun; 9(6):651-664. PubMed ID: 33762351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing CD8
    Zhang Y; Kurupati R; Liu L; Zhou XY; Zhang G; Hudaihed A; Filisio F; Giles-Davis W; Xu X; Karakousis GC; Schuchter LM; Xu W; Amaravadi R; Xiao M; Sadek N; Krepler C; Herlyn M; Freeman GJ; Rabinowitz JD; Ertl HCJ
    Cancer Cell; 2017 Sep; 32(3):377-391.e9. PubMed ID: 28898698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling.
    Zeng JS; Zhang ZD; Pei L; Bai ZZ; Yang Y; Yang H; Tian QH
    Int J Biochem Cell Biol; 2018 Feb; 95():1-8. PubMed ID: 29229426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malic enzyme 2 maintains metabolic state and anti-tumor immunity of CD8
    Zhang Z; Yang Y; Chen Y; Su J; Du W
    Mol Cell; 2024 Sep; 84(17):3354-3370.e7. PubMed ID: 39151423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells.
    Cao Y; Rathmell JC; Macintyre AN
    PLoS One; 2014; 9(8):e104104. PubMed ID: 25090630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes.
    Nishida M; Yamashita N; Ogawa T; Koseki K; Warabi E; Ohue T; Komatsu M; Matsushita H; Kakimi K; Kawakami E; Shiroguchi K; Udono H
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway.
    Zhuo Y; Li S; Hu W; Zhang Y; Shi Y; Zhang F; Zhang J; Wang J; Liao M; Chen J; Qian H; Li D; Sun C
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35577506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13
    Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y
    Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse PVRIG Has CD8
    Murter B; Pan X; Ophir E; Alteber Z; Azulay M; Sen R; Levy O; Dassa L; Vaknin I; Fridman-Kfir T; Salomon R; Ravet A; Tam A; Levin D; Vaknin Y; Tatirovsky E; Machlenkin A; Pardoll D; Ganguly S
    Cancer Immunol Res; 2019 Feb; 7(2):244-256. PubMed ID: 30659055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldolase triggers metabolic reprogramming in colorectal cancer in hypoxia and stiff desmoplastic microenvironments.
    Huang HC; Lin WR; Lim SN; Yeh CT; Yen TH; Alison MR; Chen CS
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110969. PubMed ID: 32199265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity.
    Ringel AE; Drijvers JM; Baker GJ; Catozzi A; García-Cañaveras JC; Gassaway BM; Miller BC; Juneja VR; Nguyen TH; Joshi S; Yao CH; Yoon H; Sage PT; LaFleur MW; Trombley JD; Jacobson CA; Maliga Z; Gygi SP; Sorger PK; Rabinowitz JD; Sharpe AH; Haigis MC
    Cell; 2020 Dec; 183(7):1848-1866.e26. PubMed ID: 33301708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NaCl enhances CD8
    Scirgolea C; Sottile R; De Luca M; Susana A; Carnevale S; Puccio S; Ferrari V; Lise V; Contarini G; Scarpa A; Scamardella E; Feno S; Camisaschi C; De Simone G; Basso G; Giuliano D; Mazza EMC; Gattinoni L; Roychoudhuri R; Voulaz E; Di Mitri D; Simonelli M; Losurdo A; Pozzi D; Tsui C; Kallies A; Timo S; Martano G; Barberis E; Manfredi M; Rescigno M; Jaillon S; Lugli E
    Nat Immunol; 2024 Oct; 25(10):1845-1857. PubMed ID: 39198631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex.
    He X; Li M; Yu H; Liu G; Wang N; Yin C; Tu Q; Narla G; Tao Y; Cheng S; Yin H
    PLoS Biol; 2020 Dec; 18(12):e3000803. PubMed ID: 33275593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics Can Boost the Antitumor Immunity of CD8
    Mao J; Zhang SZ; Du P; Cheng ZB; Hu H; Wang SY
    J Immunol Res; 2020; 2020():4092472. PubMed ID: 32455139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma.
    Wang B; Tang J; Liao D; Wang G; Zhang M; Sang Y; Cao J; Wu Y; Zhang R; Li S; Ding W; Zhang G; Kang T
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S684-92. PubMed ID: 23943028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-33 activates mTORC1 and modulates glycolytic metabolism in CD8
    Liang Y; Wang X; Wang H; Yang W; Yi P; Soong L; Cong Y; Cai J; Fan X; Sun J
    Immunology; 2022 Jan; 165(1):61-73. PubMed ID: 34411293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.
    Finlay DK; Rosenzweig E; Sinclair LV; Feijoo-Carnero C; Hukelmann JL; Rolf J; Panteleyev AA; Okkenhaug K; Cantrell DA
    J Exp Med; 2012 Dec; 209(13):2441-53. PubMed ID: 23183047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.